Showing results (51-60 of 161) with videos related to
Sort By:
Pageof 17
Anticancer Research|July 31, 2013
Investigation of FANCA mutations in Greek patientsNikoletta Selenti, Christalena Sofocleous, Antonis Kattamis, et al.Haematologica|September 8, 2006
A prospective randomized controlled trial on the safety and efficacy of alternating deferoxamine and deferiprone in the treatment of iron overload in patients with thalassemiaRenzo Galanello, Antonis Kattamis, Antonio Piga, et al.Pediatric Blood & Cancer|May 16, 2024
Iron chelation therapy for children with transfusion-dependent β-thalassemia: How young is too young?Gian Luca Forni, Antonis Kattamis, Kevin H M Kuo, et al.European Journal of Internal Medicine|November 8, 2015
Development of a new disease severity scoring system for patients with non-transfusion-dependent thalassemiaM Domenica Cappellini, John B Porter, Khaled M Musallam, et al.Journal of Magnetic Resonance Imaging : JMRI|May 25, 2011
Impact of magnetic resonance imaging on cardiac mortality in thalassemia majorGiorgos Chouliaras, Vasilios Berdoukas, Vassilis Ladis, et al.JBMR Plus|April 20, 2026
Romosozumab for the treatment of thalassemia-associated osteoporosis in two female patientsMaria P Yavropoulou, Maria-Evangelia Koloutsou, Polyxeni Delaporta, et al.Hemoglobin|December 6, 2014
Hb Souli, a 6 bp in-frame deletion on the HBA2 gene (HBA2: c.[41-46delCCTGGG]) leads to α-thalassemia intermedia, when in trans to a single α-globin gene deletionAntonis Kattamis, Polyxeni Delaporta, Irene Fylaktou, et al.Orphanet Journal of Rare Diseases|November 26, 2025
Safety and pharmacodynamics of the ferroportin inhibitor vamifeport in patients with non-transfusion-dependent β-thalassemia: results from a randomized phase 2a studyAntonis Kattamis, Ali Taher, Vip Viprakasit, et al.Experimental Hematology & Oncology|August 15, 2020
Two-year long safety and efficacy of deferasirox film-coated tablets in patients with thalassemia or lower/intermediate risk MDS: phase 3 results from a subset of patients previously treated with deferasirox in the ECLIPSE studyImmacolata Tartaglione, Raffaella Origa, Antonis Kattamis, et al.European Journal of Haematology|February 4, 2011
Survival in a large cohort of Greek patients with transfusion-dependent beta thalassaemia and mortality ratios compared to the general populationVassilis Ladis, Giorgos Chouliaras, Vasilios Berdoukas, et al.Pageof 17